These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


408 related items for PubMed ID: 14612418

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles.
    Itoh K, Wakabayashi N, Katoh Y, Ishii T, O'Connor T, Yamamoto M.
    Genes Cells; 2003 Apr; 8(4):379-91. PubMed ID: 12653965
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers.
    Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang MI, Kobayashi A, Yamamoto M, Kensler TW, Talalay P.
    Proc Natl Acad Sci U S A; 2004 Feb 17; 101(7):2040-5. PubMed ID: 14764894
    [Abstract] [Full Text] [Related]

  • 8. Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2.
    Sekhar KR, Yan XX, Freeman ML.
    Oncogene; 2002 Oct 03; 21(44):6829-34. PubMed ID: 12360409
    [Abstract] [Full Text] [Related]

  • 9. Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes.
    Kobayashi A, Ohta T, Yamamoto M.
    Methods Enzymol; 2004 Oct 03; 378():273-86. PubMed ID: 15038975
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress.
    Zhang DD, Hannink M.
    Mol Cell Biol; 2003 Nov 03; 23(22):8137-51. PubMed ID: 14585973
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione.
    Kwak MK, Itoh K, Yamamoto M, Sutter TR, Kensler TW.
    Mol Med; 2001 Feb 03; 7(2):135-45. PubMed ID: 11471548
    [Abstract] [Full Text] [Related]

  • 15. Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome.
    Katoh Y, Iida K, Kang MI, Kobayashi A, Mizukami M, Tong KI, McMahon M, Hayes JD, Itoh K, Yamamoto M.
    Arch Biochem Biophys; 2005 Jan 15; 433(2):342-50. PubMed ID: 15581590
    [Abstract] [Full Text] [Related]

  • 16. Ultraviolet A irradiation induces NF-E2-related factor 2 activation in dermal fibroblasts: protective role in UVA-induced apoptosis.
    Hirota A, Kawachi Y, Itoh K, Nakamura Y, Xu X, Banno T, Takahashi T, Yamamoto M, Otsuka F.
    J Invest Dermatol; 2005 Apr 15; 124(4):825-32. PubMed ID: 15816842
    [Abstract] [Full Text] [Related]

  • 17. Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers.
    Kwak MK, Wakabayashi N, Kensler TW.
    Mutat Res; 2004 Nov 02; 555(1-2):133-48. PubMed ID: 15476857
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation.
    Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S, Imakado S, Kotsuji T, Otsuka F, Roop DR, Harada T, Engel JD, Yamamoto M.
    Nat Genet; 2003 Nov 02; 35(3):238-45. PubMed ID: 14517554
    [Abstract] [Full Text] [Related]

  • 20. Regulation of proteasome complexes by gamma-interferon and phosphorylation.
    Rivett AJ, Bose S, Brooks P, Broadfoot KI.
    Biochimie; 2001 Nov 02; 83(3-4):363-6. PubMed ID: 11295498
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.